E-Z-EM launches new blood analyser:
This article was originally published in Clinica
Executive Summary
E-Z-EM, of Lake Success, New York, has formally launched its EZ CHEM blood analyser, a convenient point-of-care blood assay device for use in patients due to undergo certain imaging procedures. The device assesses kidney function by analysing a finger prick sample of blood for levels of creatinine, an indicator of a patient's renal function. Renal function of some patients, usually older patients or those with diabetes or kidney impairment, is a measure of their ability to safely receive IV contrast imaging agents prior to CT and MR imaging procedures. Currently, blood tests must be sent to a lab before the patient can undergo these. Waltham, Massachusetts-based Nova Biomedical, E-Z-EM's development partner for the analyser, gained US 510(k) clearance for the base technology, called StatSensor, in May.
You may also be interested in...
Hanmi-OCI Merger Hits Wall As Brothers Win Shareholder Vote, Board Seats
The planned merger of Korea's Hanmi Pharm Group with OCI Group hits a major speed bump as the two sons of Hanmi's founder and other candidates recommended by them secture board seats. But it remains to be seen how the Lim brothers will fulfil their ambitious promises.
Beauty Firms Using AI-Based Tools Could Be Subject To Health Privacy Laws In US States
Using AI-based programs to collect and store consumer information risks running afoul of new health privacy laws cropping up in US states. Lack of federal regulation or guidance on the issue is one of the biggest challenges for beauty firms deploying AI, according to Stacy Marcus, partner at Reed Smith LLP.
Mustang Bio Enters Race For CAR-T In Autoimmune Disease
The biotech company’s CEO talked to Scrip about plans to bring the CD20-targeting CAR-T MB-106 into an investigator-sponsored Phase I trial later this year.